SCI & TECH● LOWAug 19 · Aug 19, 2026, 8:59 AM
Novo Nordisk tests low-dose Wegovy pill in new study
Seeking Alpha Tech
Novo Nordisk is conducting a new study to test a low-dose pill version of its drug, Wegovy. This research could impact future treatment options.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH18m agoSTMicroelectronics reveals lineup of automotive sensors for safety and driver assistanceSeeking Alpha TechSCI & TECH22m agoEurope can still shape the rules of AISouth China Morning PostSCI & TECH23m agoKano students win national entrepreneurship contest with AI farming platformPremium TimesSCI & TECH1h agoMoonshot AI resets Kimi K3.1 Pro quotas after user complaintsSeeking Alpha Tech